Results 241 to 250 of about 130,730 (348)
The Immune Microenvironment in Liver Cancer: From Analysis to Targeting
This review explores how smart nanomedicines overcome the immunosuppressive tumor microenvironment in liver cancer. It details targeted delivery strategies and immune reprogramming mechanisms, including remodeling abnormal physiology, modulating metabolism, and inducing immunogenic cell death. The article highlights the paradigm shift toward multimodal
Jiaming Lan +5 more
wiley +1 more source
Can proton pump inhibitors increase the risk of sudden unexpected death in Parkinson's disease (SUDPAR)? [PDF]
Menezes-Rodrigues FS +5 more
europepmc +1 more source
RAPID HEARTBURN RELIEF WITH PROTON PUMP INHIBITOR: HYPE OR REALITY
Kenneth R. DeVault
openalex +1 more source
Advanced Therapeutic Approach Based on LDHs–Mimetic Oxidoreductase
Overview of Sructure, Multienzyme‐mimicking Activity and Advanced Therapeutic Approach Based on LDHs–Mimetic Oxidoreductase. Abstract Redox dysregulation is recognized as a key driver in the pathophysiology of numerous refractory diseases, contributing significantly to the progression and poor prognosis.
Kai Song +9 more
wiley +1 more source
In vitro susceptibility testing of Trichomonas gallinae strains to proton pump inhibitors and nitroimidazoles. [PDF]
Kerek Á +6 more
europepmc +1 more source
Acinetobacter regulates dinotefuran tolerance in Propylea japonica by mediating the expression of the horizontally transferred gene PjDUF1. Abstract Insect–microbial symbiont relationships are widespread in nature and often involve lateral gene transfer.
Ningbo HuangFu +10 more
wiley +1 more source
Pharmacodynamics, pharmacokinetics, interactions with other drugs, toxicity and clinical effectiveness of proton pump inhibitors. [PDF]
Wołowiec Ł +7 more
europepmc +1 more source
Fe‐based magnetic nanocubes conjugated with TRPV1 antibodies (FeNCs‐TRPV1) are developed for the specific targeting of TRPV1 channels. Intraspinally injected FeNCs‐TRPV1 induces TRPV1 desensitization in rats exposed to repetitive and transient ACMF.
Xueying Cheng +15 more
wiley +1 more source

